Brief: SeaStar Medical Expects To Disclose Material Weakness In Its Design, Operation Of Effective Internal Controls Over Financial Reporting
27/03/2024 12:38
March 27 (Reuters) - SeaStar Medical Holding Corp
ICU.O :
* SEASTAR MEDICAL-EXPECTS TO DISCLOSE IN FORM 10-K MATERIAL
WEAKNESS IN ITS DESIGN AND OPERATION OF EFFECTIVE INTERNAL
CONTROLS OVER FINANCIAL REPORTING
Source text for Eikon: ID:n0000950170-24-036837
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview